Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11686328 | chr2:233145683 | G/A | 3.88E-5 | 176 | 25.87 | 22.63 | 9.13 | KM Plot |
PCPG | rs116881803 | chr10:69738319 | G/T | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs11688688 | chr2:122037415 | A/G | 0.000449 | 171 | 25.97 | 19.2 | 24.1 | KM Plot |
PCPG | rs11688732 | chr2:239096622 | G/T | 3.1E-5 | 171 | 29.43 | 18.2 | 13.22 | KM Plot |
PCPG | rs11690298 | chr2:176152165 | T/C | 0.000128 | 176 | 6.62 | 28.95 | 25.28 | KM Plot |
PCPG | rs116934693 | chr12:56696545 | T/G | 1.04E-7 | 177 | 25.53 | 27.33 | 0.8 | KM Plot |
PCPG | rs11695300 | chr2:107237457 | G/A | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs117012037 | chr10:69789194 | G/A | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs11701226 | chr21:38472454 | G/A | 9.44E-9 | 175 | 25.35 | 25.87 | 3.83 | KM Plot |
PCPG | rs11701444 | chr21:38467556 | G/A | 9.32E-9 | 176 | 25.17 | 25.87 | 3.83 | KM Plot |
PCPG | rs11702020 | chr21:38443477 | T/C | 4.52E-6 | 178 | 25 | 26.57 | 3.7 | KM Plot |
PCPG | rs11702061 | chr21:38439686 | A/G | 4.52E-6 | 178 | 25 | 26.57 | 3.7 | KM Plot |
PCPG | rs11702610 | chr21:38503870 | T/G | 1.11E-16 | 174 | 24.7 | 25.63 | 3.17 | KM Plot |
PCPG | rs117028299 | chr7:105162310 | T/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs11706150 | chr3:195758848 | A/G | 0.000116 | 170 | 24.62 | 36 | 10.57 | KM Plot |